Blocking the m(6)Am methyltransferase PCIF1 in macrophages attenuates colitis progression by preventing neuronal damage.

Blocking the m(6)Am methyltransferase PCIF1 in macrophages reduces colitis progression and protects enteric neurons from inflammation-driven degeneration.

• Why it matters: Understanding macrophage-nerve interactions is essential for developing treatments for inflammatory bowel disease (IBD), but the mechanisms remain unclear.
• What they did: The study used genetic and pharmacological approaches to inhibit Pcif1 in macrophages, revealing that Pcif1 deficiency increases ECM accumulation and promotes neuronal maturation, thereby attenuating colitis in models.
• The result: Inhibiting PCIF1 enhances ECM deposition and suppresses neuronal loss, suggesting that targeting the m(6)Am machinery may offer a new therapeutic strategy for preventing neuronal damage in IBD.